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Immediate hypersensitivity reactions remain a problem and 
concern following the application of non-ionic iodinated 
contrast media (ICMs). Although the incidence rate of such 
adverse reactions is low, the frequent and intense use of 
ICMs compensates the low percentages. Consequently, each 
radiological clinic/unit has a substantial number of patients 
with immediate hypersensitivity reactions. As to whether 
it could be possible to reduce the incidence of immediate 
hypersensitivity reactions, is yet one great-unsolved question. 
Park and colleagues addressed this central question 
in their recently published retrospective study (1). They 
analysed the effect of lowering both the dose and the 
injection speed rate of non-ionic ICMs for CT in adult 
patients. They compared the following two study periods: 
(I) The control period (CT tube voltage of 120 kVp, 
2 mL ICM/kg up to a maximum of 150 mL, and an 
injection speed of 3 or 4 mL/s) examined between 
August 2016 and January 2017; 
(II) The interventional period (CT tube voltage of 
100 kVp, 1.5 mL ICM/kg up to a maximum of 
130 mL, and an injection speed of 2.5 or 3 mL/s) 
between August 2017 and January 2018. 
They included a substantial number of patients (22,291 
vs. 23,352) in their study and revealed a significant (P=0.03) 
decrease of immediate hypersensitivity reactions from 1.86% 
(468 of 25,119 examinations; 95% CI: 1.70–2.04%) to 1.42% 
(376 of 26,491 examinations; 95% CI: 1.28–1.57%). 
The authors concluded that immediate hypersensitivity 
reactions to ICMs are not entirely independent of dose and 
injection speed of the contrast agent (1). Lowering the dose 
and injection speed of ICMs are easy to perform measures, 
and should be used regularly in radiology routine settings. 
The general slogan ‘less is more’ is also true for contrast-
enhanced CT scans. Low-dose ICM has several advantages, 
the patients’ organism is less loaded with contrast 
material, the kidney function is altered less, and finally yet 
importantly, the incidence of immediate hypersensitivity 
reactions is lowered. Every single patient benefits from low-
dose ICM procedures, especially elderly and critical ill ones. 
The study by Park and colleagues is very well done 
and written, and shows clear results (1). I congratulate the 
authors for their excellent work. In addition, I like to take 
this opportunity to comment some points: 
(I) What should or what could we do to reduce further 
the incidence of immediate ICM-hypersensitivity 
reactions? Currently, this is a central question in 
clinical radiology. I think there are the following 
options to achieve this goal (Table 1). 
Editorial Commentary
Lower dose and lower injection speed of iodinated contrast 
media: a new strategy to reduce the incidence rate of immediate 
hypersensitivity reactions 
Ingrid B. Böhm
Department of Diagnostic, Interventional, and Pediatric Radiology, Inselspital, University of Bern, Bern, Switzerland
Correspondence to: Ingrid B. Böhm, MD. Department of Diagnostic, Interventional, and Pediatric Radiology, Inselspital, University of Bern, 
Freiburgstrasse 10, CH-3010 Bern, Switzerland. Email: ingrid.boehm@insel.ch. 
Provenance and Peer Review: This article was commissioned by the editorial office, Quantitative Imaging in Medicine and Surgery. The article did not 
undergo external peer review.
Comment on: Park HJ, Son JH, Kim TB, Kang MK, Han K, Kim EH, Kim AY, Park SH. Relationship between Lower Dose and Injection Speed of 
Iodinated Contrast Material for CT and Acute Hypersensitivity Reactions: An Observational Study. Radiology. 2019;293:565-72. 
Submitted Feb 13, 2020. Accepted for publication Feb 28, 2020.
doi: 10.21037/qims.2020.03.09
View this article at: http://dx.doi.org/10.21037/qims.2020.03.09
885
s
o
u
r
c
e
:
 
ht
tp
s:
//
do
i.
or
g/
10
.7
89
2/
bo
ri
s.
14
38
66
 
| 
do
wn
lo
ad
ed
: 
13
.5
.2
02
0
884 Böhm. Strategy to reduce ICM-hypersensitivity
© Quantitative Imaging in Medicine and Surgery. All rights reserved.   Quant Imaging Med Surg 2020;10(4):883-885 | http://dx.doi.org/10.21037/qims.2020.03.09
(i) As shown by Park and colleagues (1), lowering 
both the  ICM-dose  and the  in ject ion 
speed is a reliable method to decrease the 
incidence of immediate ICM-hypersensitivity 
reactions. We should broadly perform this in 
patients undergoing contrast-enhanced CT-
examinations all over the world;
(ii) Another method to reduce the incidence 
of ICM-hypersensitivity reactions could 
be the reduction of the environmental 
contamination with ICM. Iodinated contrast 
materials are renal eliminated in chemical 
intact form. Therefore, via wastewater ICMs 
reach the environment and contaminate 
ground and drinking water (2). Uptake of 
ICM-contaminated drinking water could 
be a possible source for a (silent) ICM-
sensitization. Following this event, ICM-
injection for contrast-enhanced procedures 
could lead in such individuals to clinical 
manifest ICM-hypersensitivity reactions. This 
means, the reduction of the ICM-dose for 
contrast-enhanced radiological procedures has 
in the long run and far-reaching consequences; 
(iii) Patients reacting in a setting of contrast-
enhanced procedures are suspected mainly or 
only to have an ICM-related adverse reaction/
hypersensitivity. Usually, radiologists do not 
perform a detailed search for the true culprit 
agent. As shown previously, in nearly 75%, 
adverse reactions are caused by contrast agents, 
and in ~10%, these reactions have other reasons 
(3). Consequently, it is useful to search for the 
individual relevant cause in patients suspected for 
ICM-hypersensitivity. In other words, without 
an exclusion of non-ICM culprit agents the 
mentioned incidences could be overestimated;
(iv) Exact documentations of ICM-hypersensitivity 
reactions enable us to perform an individual 
management program followed by a safe ICM-
application. Such actions also decrease the 
incidence of ICM-hypersensitivity (4). The 
more exact the documentation, the more 
exact the subsequent individual management. 
Although recommendations concerning the 
documentation are boring, they are very 
important for the patients’ safety. We should 
document the three following parameters: date 
of the adverse reaction, name of the culprit 
ICM/agent, and the clinical symptoms of the 
adverse reaction (5). Exact documentation 
includes the use of correct terms for the observed 
hypersensitivity. The term “iodine allergy” —
for example—should be omitted, because such 
kind of allergy does not exist (4,6). Moreover, 
the term is confusing, and leads to ineffective 
actions. In addition, there are still other terms 
like “allergy-like” and “physiological” reaction 
that are also inexact and confusing which should 
be replaced by exacter ones (6-9). Last but not 
least, the exact documentation of skin reactions 
could be challenge. Therefore, eligible overview 
articles inform radiologist about them (10).
(II) Currently, the minimal possible incidence of 
immediate ICM-hypersensitivity reactions is 
unknown. Nevertheless, the incidence is low in these 
days. Currently, contrast media have the lowest 
rate of adverse events of all drugs. This general 
accepted fact clearly points to another circumstance, 
namely to the nature of the reactions. The lower 
the incidence the greater the likelihood of an allergy 
rather than an allergy-like reaction. Unfortunately, 
Table 1 Actions to lower the incidence of ICM-hypersensitivity reactions
Use low-ICM dose CT examinations
Lower the injection speed of ICM
Reduce the environmental contamination with ICM 
Search and identify the culprit agent (sometimes non-ICM-substances induce the hypersensitivity)
Exactly document each ICM-hypersensitivity reaction 
Use correct terms for the observed reactions (type A and type B reactions instead of physiological and allergy-like reaction), and omit “iodine 
allergy”
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even  wi thout  a l l ergy-workout  immedia te 
hypersensitivity reactions still are called ‘allergy-
like’ (6). Since this is incorrect and confusing, 
the term ‘hypersensitivity reaction’ is much more 
suitable to describe such reactions. Of course, in the 
cohort of ICM-hypersensitivity reactions there will 
be both, patients with true allergy and non-allergy 
reactions. We should be aware about this fact, and 
should always anticipate the worst case, namely the 
allergy. Moreover, a low percentage of patients with 
hypersensitivity reaction points to a special reactivity 
rather than to a simple histamine release as discussed 
by Park et al. (1).
(III) When comparing control and interventional 
period, Park et al. clearly showed a significant 
decrease of moderate to severe reactions (P=0.004), 
while mild reactions decreased not significantly (1). 
This was surprising. Because this is, exact the 
opposite of my anticipation. Possibly, a detailed 
analysis of the subgroup (n=6,207 patients) that was 
examined in both periods [i.e., the control and the 
intervention period (1)], could help to understand 
better why patients reacted and why not.  
Taken together, the recently published work by Park 
et al. (1) is a milestone paper. The authors clearly 
demonstrated in a great patient cohort that lowering 
both the ICM-dose as well as the injection speed rate, 
is accompanied by a significant drop of the incidence of 
immediate ICM-hypersensitivity reactions.
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